(MENAFN- Straits Research)
India Pharmaceutical Stability and Storage Services Market Size
The India Pharmaceutical Stability and Storage Services Market size was valued at USD 448 million in 2025 and is projected to grow from USD 500.95 million in 2026 to reach USD 1224.48 million by 2034, growing at a CAGR of 11.82% during the forecast period 2026–2034.
The pharmaceutical stability and storage services market has experienced substantial growth recently, driven by the expanding pharmaceutical industry's demand for reliable and efficient storage solutions. These services involve specialized facilities and expertise to maintain optimal conditions for pharmaceutical products, ensuring their quality and efficacy.
Top 3 Key Highlights
Storage dominated the market by services.
Large molecules dominate the market by molecules.
Outsourcing dominates the market by modes.
Download a Free Sample To learn more about this report,
India Pharmaceutical Stability and Storage Services Market Growth Factor
Rising Demand for Vaccines
The increased vaccine demand has greatly influenced the pharmaceutical stability and storage services market. The COVID-19 pandemic emphasized the importance of efficient vaccine storage and distribution for widespread immunization. The development and deployment of multiple COVID-19 vaccines required specific storage conditions, such as ultra-low temperatures for mRNA vaccines like Pfizer-BioNTech and Moderna.
This led to a surge in demand for storage services equipped with advanced cold chain infrastructure to ensure the stability of vaccines. Pharmaceutical stability and storage service providers were crucial in supporting vaccine manufacturers, governments, and healthcare organizations by offering temperature-controlled storage facilities, including specialized freezers and refrigeration units, to preserve the vaccines' effectiveness.
Restraining Factor
Heavy Reliance on Highly Skilled Workforce
The pharmaceutical stability and storage services in the Indian market rely on a highly skilled workforce to meet its complex requirements. Specialized knowledge and expertise are essential to effectively handle, store, and maintain pharmaceutical products. Managing storage facilities and equipment is a critical area that demands professionals with a comprehensive understanding of temperature-controlled environments, monitoring systems, and quality control procedures.
Given the stringent and evolving regulatory landscape, compliance with international standards like Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) is vital. Consequently, the market requires professionals well-versed in regulatory affairs and quality management. These individuals ensure adherence to regulations, conduct audits, implement quality control measures, and address non-compliance issues.
Market Opportunity
Demand for Biopharmaceuticals and Personalized Medicine
The pharmaceutical stability and storage services market offers significant potential for growth and expansion driven by various factors. The expanding pharmaceutical industry and the increasing complexity of drug formulations demand specialized storage solutions. Developing new drugs and biologics necessitates precise temperature control, humidity regulation, and protection from light to preserve their stability and effectiveness.
The growing demand for biopharmaceuticals and personalized medicine further contributes to the need for specialized storage and stability services. Biologics, including vaccines, monoclonal antibodies, and cell therapies, often require stringent temperature control and careful handling. Additionally, the development and commercialization of biosimilars add to the market opportunities as these complex products require specific storage conditions to maintain their stability.
Services Insights
Storage dominated the market and is expected to register a CAGR of 10.4% over the forecast period.
Request Customization to receive a tailored report.
Molecules Insights
The Large molecules dominate the market and are expected to register a CAGR of 10.3% over the forecast period.
Modes Insights
The outsourcing market is expected to register a CAGR of 11.2% over the forecast period.
Speak to an Analyst to discuss market opportunities.
Regional Insights
The pharmaceutical stability and storage services market in the Asia Pacific region is experiencing rapid growth and is a dynamic sector within the pharmaceutical industry. This region presents a significant market for stability and storage services. The market's expansion is propelled by the rapid growth of the pharmaceutical and biopharmaceutical industries, driven by a large population, rising healthcare expenditures, and increasing pharmaceutical manufacturing, research and development, and clinical trial activities.
List of Key and Emerging Players in India Pharmaceutical Stability and Storage Services Market
Catalent Inc.
May BioServices
Almac Group
Charles River Laboratories International, Inc.
Alcami Corporation
PD Partners
Q Laboratories
Key Industry Developments
July 2025: Callan JMB Inc. established Callan JMB Services (India) Private Limited and announced the development of a temperature-controlled pharmaceutical warehouse in Pune, Maharashtra. The facility is designed to provide storage and distribution services across multiple temperature ranges, including -80°C storage for clinical trial samples and pharmaceutical products.
September 2025: Cryoport Systems expanded its pharmaceutical logistics capabilities in India by strengthening its GDP-compliant temperature-controlled logistics network through regional partnerships, supporting pharmaceutical stability studies and clinical trial storage requirements across the country.
January 2026: Eurofins Scientific expanded its pharmaceutical testing and stability services in India by enhancing laboratory capabilities for ICH-compliant stability testing, analytical services, and long-term sample storage to support domestic and global pharmaceutical manufacturers.
May 2026: Kuehne+Nagel inaugurated a new temperature-controlled healthcare logistics facility in Hyderabad, expanding its HealthChain-certified infrastructure in India. The facility strengthens pharmaceutical storage, cold chain handling, and compliant distribution services for drug manufacturers and clinical supply chains.
Report Scope
Comments
No comment